Involvement of transporter associated with antigen processing 2 (TAP2) gene polymorphisms in hepatitis C virus infection

Gastroenterology

Volumn 116, Issue 5, 1999, Pages 1149-1154

  Kuzushita, N ^a   Hayashi, N ^a   Kanto, T ^a   Takehara, T ^a   Tatsumi, T ^a   Katayama, K ^a   Ohkawa, K ^a   Ito, A ^a   Kasahara, A ^a   Moribe, T ^a   Sasaki, Y ^a   Hori, M ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CARRIER PROTEIN;

ADULT; ANTIGEN PRESENTATION; ARTICLE; CHRONIC LIVER DISEASE; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE LOCUS; HAPLOTYPE; HEPATITIS C VIRUS; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0032952504     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(99)70018-1     Document Type: Article

References (45)

1. QL Choo G Kuo AJ Weiner LR Overby DW Bradley M Houghton Isolation of a cDNA clone derived from a blood borne non-A, non-B viral hepatitis genome Science 244 1989 359 362
2. LB Seeff Z Buskell-Bales EC Wright SJ Durako HJ Alter FL Iber FB Hollingger G Gitnick RG Knodell RP Perrillo CE Stevens CG Hollinsworth the National Heart, Lung, and Blood Institute Study Group Long-term mortality after transfusion associated non-A, non-B hepatitis N Engl J Med 327 1992 1906 1911
3. K Kiyosawa T Sodeyama E Tanaka Y Gibo K Yoshizawa Y Nakano S Furuta Y Akahane K Nishioka RH Purcell HJ Alter Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus Hepatology 12 1990 671 675
4. S Brillanti M Foli S Gaiani C Masci M Miglioli L Barbara Persistent hepatitis C viraemia without liver disease Lancet 341 1993 464 465
5. N Kuzushita N Hayashi K Katayama N Hiramatsu M Yasumaru H Murata Y Shimizu T Yamazaki H Fushimi K Kotoh A Kasahara H Fusamoto T Kamada Increased frequency of HLA DR13 in hepatitis C virus carriers with persistently normal ALT levels J Med Virol 48 1996 1 7
6. MJ Koziel D Dudley JT Wong J Dienstag M Houghton R Ralston BD Walker Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis J Immunol 149 1992 3339 3344
7. MJ Koziel D Dudley N Afdhal A Grakoui CM Rice QL Choo M Houghton BD Walker HLA class I–restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release J Clin Invest 96 1995 2311 2321
8. K Hiroishi H Kita M Kojima H Okamoto T Moriyama T Kaneko T Ishikawa S Ohnishi T Aikawa N Tanaka Y Yazaki K Mitamura M Imawari Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection Hepatology 25 1997 705 712
9. FM Rammensee K Falk O Rötzschke Peptides naturally presented by MHC class I molecules Annu Rev Immunol 11 1993 213 244
10. A Kelly SH Powis LA Kerr I Mockridge T Elliot J Bastin B Uchanska-Ziegler A Ziegler J Trowsdale A Townsend Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex Nature 355 1992 641 644
11. SJ Powis A Townsend EV Deverson J Bastin GW Butcher JC Howard Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter Nature 354 1991 528 531
12. + T cells Cell 71 1992 1205 1214
13. T Spies V Cerundolo P Colonna P Cresswell A Townsend R DeMars Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer Nature 355 1992 644 646
14. S Bahram D Arnold M Bresnahan JL Strominger T Spies Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II region Proc Natl Acad Sci USA 88 1991 10094 10098
15. M Colonna M Bresnahan S Bahram JL Strominger T Spies Allelic variants of the human putative peptide transporter involved in antigen processing Proc Natl Acad Sci USA 89 1992 3932 3936
16. T Spies R De Mars Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter Nature 351 1991 323 324
17. SJ Powis EV Deverson WJ Coadwell A Ciruela NS Huskisson H Smith GW Butcher JC Howard Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule Nature 357 1992 211 215
18. SJ Powis LL Young E Joly PJ Barker L Richardson RP Brandt CJ Melief JC Howard GW Butcher The rat cim effect: TAP allele-dependent changes in a class I MHC anchor motif and evidence against C-terminal trimming of peptides in the ER Immunity 4 1996 159 165
19. F Momburg EA Armandola M Post GJ Hämmerling Residues in TAP2 peptide transporters controlling substrate specificity J Immunol 156 1996 1756 1763
20. L Alric M Fort J Izopet JP Vinel JP Charlet J Selves J Puel JP Pascal M Duffaut M Abbal Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection Gastroenterology 113 1997 1675 1681
21. C Tibbs PT Donaldson JA Underhill L Thomson K Manabe R Williams Evidence that the HLA DQA1*03 allele confers protection from chronic HCV-infection in Northern European Caucasoids Hepatology 24 1996 1342 1345
22. G Peano G Menardi A Ponzetto LM Fenoglio HLA-DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection? Arch Intern Med 154 1994 2733 2736
23. N Kuzushita N Hayashi T Moribe K Katayama T Kanto S Nakatani T Kaneshige T Tatsumi A Ito K Mochizuki Y Sasaki A Kasahara M Hori Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus Hepatology 27 1998 240 244
24. C Zavaglia M Martinetti E Silini R Bottelli C Daielli M Asti A Airoldi L Salvaneschi MU Mondelli G Ideo Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C J Hepatol 28 1998 1 7
25. R Cambell J Trowsdale Map of human MHC Immunol Today 14 1993 349 352
26. M Cullen H Erlich W Klitz M Carrington Molecular mapping of a recombination hotspot located in the second intron of the human TAP2 locus Am J Hum Genet 56 1995 1350 1358
27. VJ Desmet M Gerber JY Hoofnagle M Manns PJ Scheuer Classification of chronic hepatitis: diagnosis, grading and staging Hepatology 19 1994 1513 1520
28. E Mita N Hayashi H Hagiwara K Ueda Y Kanazawa A Kasahara H Fusamoto T Kamada Predicting interferon therapy efficacy from hepatitis C virus genotype and RNA titer Dig Dis Sci 39 1994 977 982
29. P Simmonds A Alberti HJ Alter F Bonino DW Bradley C Brechot JT Brouwer SW Chan K Chayama DS Chen QL Choo M Colombo TM Cuypers T Date GM Dusheiko JI Esteban O Fay SJ Hadziyannis J Han A Hatzadis EC Holmes EC Hotta M Houghton B Irvine M Kohara JA Kolberg G Kuo JYN Lau PN Lelie G Martens F McOmish T Miyamura M Mizokami A Nomato AM Prince HW Reesink C Rice M Roggendorf SW Shalm T Shikata K Simotohno L Stuyver C Trepo A Weiner PL Yap MS Urdea A proposed system for the nomenclature of hepatitis C virus genotypes Hepatology 19 1994 1321 1324
30. JYN Lau GL Davis J Kniffen K-P Qian MS Urdea CS Chan M Mizokami PD Neuwald JC Wilber Significance of serum hepatitis C virus RNA levels in chronic hepatitis C Lancet 341 1993 1501 1504
31. A Fraile J Vinasco A Nieto E Pareja J Martín Typing for TAP alleles using PCR-RFLP with amplification-created restriction sites Tissue Antigens 47 1996 346 352
32. S Kuwata M Yanagisawa S Saeki H Nakagawa T Etoh K Tokunaga T Juji Y Shibata Polymorphisms of transporter associated with antigen processing genes in atopic dermatitis J Allergy Clin Immunol 94 1994 565 574
33. T Kaneshige K Takagi S Nakamura T Hirasawa M Sada K Uchida Genetic analysis using fingernail DNA Nucleic Acids Res 20 1992 5489 5490
34. JG Bodmer SG Marsh ED Albert WF Bodmer RE Bontrop D Charron B Dupont HA Erlich B Mach WR Mayer P Parham T Sasazuki GMT Schreuder JL Strominger A Svejgaard PI Terasaki Nomenclature for factors of the HLA system, 1995 Tissue Antigens 46 1995 1 18
35. M Ishihara S Ohno T Ishida T Naruse M Kagiya N Mizuki E Maruya H Saji H Ińoko Analysis of allelic variation of the TAP2 gene in sarcoidosis Tissue Antigens 49 1997 107 110
36. T Kaneshige M Hashimoto Y Matsumoto T Kinoshita T Hirasawa K Uchida H Inoko Serologic and nucleotide sequencing analyses of a novel DR52-associated DRB1 allele with DR'NJ25' specificity, designated DRB1*1307 Hum Immunol 41 1994 151 159
37. T Moribe T Kaneshige M Hirakata T Mimori M Akitsuki H Inoko Identification of a DRB1*0405 variant (DRB1*04052) using the PCR-RFLP method Tissue Antigens 47 1996 450 453
38. DP Sengar R Goldstein Comprehensive typing of DQB1 alleles by PCR-RFLP Tissue Antigens 43 1994 242 248
39. A Svejgaard LP Ryder HLA and disease associations: detecting the strongest association Tissue Antigens 43 1994 18 27
40. W McGuire AVS Hill CEM Allsopp BM Greenwood D Kwjatkowski Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria Nature 371 1994 508 511
41. RA Kaslow M Carrington R Apple L Park A Munoz AJ Saah JJ Goedert C Winkler SJ ó Brien C Rinaldo R Detels W Blattner J Phair H Erlich DL Mann Influence of combinations of human major histocompatibility complex genes on the courses of HIV-1 infection Nat Med 2 1996 405 411
42. T Höhler G Gerken PM Schneider KH Meyer zum Büshenfelde C Rittner Antigen-processing polymorphisms in chronic hepatitis C infection Exp Clin Immunogenet 13 1996 7 11
43. P Klenerman S Rowland-Jones S McAdam J Edwards S Daenke D Lalloo B Koppe W Rosenberg D Boyd A Edwards P Giangrande RE Phillips AJ McMichael Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants Nature 369 1994 403 407
44. A Bertoletti A Sette FV Chisari A Penna M Levrero MD Carli F Fiaccadori C Ferrari Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells Nature 369 1994 407 410
45. T Kaneko T Moriyama K Udaka K Hiroishi H Kita H Okamoto H Yagita K Okumura M Imawari Impaired induction of cytotoxic T lymphocytes by antagonism of a weak agonist borne by a variant hepatitis C epitope Eur J Immunol 27 1997 1782 1787